Skip to content
Resources > Reports

The Ultimate Buyer’s Guide for Expert Insights

Expert networks are the catalysts that transform informational deficiencies into opportunities by forming connections with subject matter experts to accelerate primary investment research. First-hand expert perspectives help investment researchers capture a comprehensive view of any trend, market, or company to make well-informed investment decisions.

The expert network industry is saturated with traditional expert networks, however not all network providers are created equal. In this buyer’s guide, we explore the following values you should look for in an expert network to meet your investment research needs:

  • Powerful AI capabilities to streamline and speed up access to quality experts
  • Industry-leading compliance to provide content you trust
  • Quality screened experts, custom vetted for your specific research projects
  • Industry experts with subject mastery to ensure reliable and valuable insights
  • Competitive pricing to outperform competitors without the associated costs

Download our buyer’s guide now to discover the right expert network for you.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.